BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32474861)

  • 1. Progranulin expression induced by follicle-stimulating hormone in ovarian cancer cell lines depends on the histological subtype.
    Perez-Juarez CE; Arechavaleta-Velasco F; Mendez C; Díaz-Cueto L
    Med Oncol; 2020 May; 37(7):59. PubMed ID: 32474861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway.
    Yang Y; Zhang J; Zhu Y; Zhang Z; Sun H; Feng Y
    Int J Gynecol Cancer; 2014 Nov; 24(9):1564-74. PubMed ID: 25340291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of PI3K/AKT/mTOR and MAPK signaling pathways decreases progranulin expression in ovarian clear cell carcinoma (OCCC) cell line: a potential biomarker for therapy response to signaling pathway inhibitors.
    Perez-Juarez CE; Arechavaleta-Velasco F; Zeferino-Toquero M; Alvarez-Arellano L; Estrada-Moscoso I; Diaz-Cueto L
    Med Oncol; 2019 Nov; 37(1):4. PubMed ID: 31713081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of PI3K/Akt/NF-κB signal pathway on FSH facilitation on cell proliferation and invasion by human epithelial ovarian cancer].
    Xu CL; Lu XL; Yan XN; Wang HL; Chen SQ
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):134-8. PubMed ID: 22455747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicle-stimulating hormone promotes the proliferation of epithelial ovarian cancer cells by activating sphingosine kinase.
    Song K; Dai L; Long X; Wang W; Di W
    Sci Rep; 2020 Aug; 10(1):13834. PubMed ID: 32796926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of follicle stimulating hormone on proliferation, apoptosis, migration and invasion of ovarian carcinoma cells: an in vitro experiment].
    Huang Y; Zhao YQ; Su M; Gao SJ; Jin HY; Feng YJ
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2512-4. PubMed ID: 18067819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary study on pathway of follicle-stimulating hormone on human epithelial ovarian cancer cell proliferation].
    Sheng L; Liu DY; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):752-5. PubMed ID: 14728848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of miR-503 contributes to the development of drug resistance in ovarian cancer by targeting PI3K p85.
    Wu D; Lu P; Mi X; Miao J
    Arch Gynecol Obstet; 2018 Mar; 297(3):699-707. PubMed ID: 29327155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway.
    Zhang Z; Zhu Y; Lai Y; Wu X; Feng Z; Yu Y; Bast RC; Wan X; Xi X; Feng Y
    Int J Oncol; 2013 Oct; 43(4):1194-204. PubMed ID: 23921511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells.
    Choi JH; Choi KC; Auersperg N; Leung PC
    Cancer Res; 2006 Apr; 66(7):3912-20. PubMed ID: 16585220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicle-stimulating hormone promoted pyruvate kinase isozyme type M2-induced glycolysis and proliferation of ovarian cancer cells.
    Li S; Ji X; Wang R; Miao Y
    Arch Gynecol Obstet; 2019 May; 299(5):1443-1451. PubMed ID: 30809696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmocollin 3 mediates follicle stimulating hormone-induced ovarian epithelial cancer cell proliferation by activating the EGFR/Akt signaling pathway.
    Yang X; Wang J; Li WP; Jin ZJ; Liu XJ
    Int J Clin Exp Pathol; 2015; 8(6):6716-23. PubMed ID: 26261554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway.
    Chen J; Bai M; Ning C; Xie B; Zhang J; Liao H; Xiong J; Tao X; Yan D; Xi X; Chen X; Yu Y; Bast RC; Zhang Z; Feng Y; Zheng W
    Oncogene; 2016 May; 35(19):2506-17. PubMed ID: 26364616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DEAD-Box Helicase 4 (Ddx4)
    D'Oronzo S; Silvestris E; Lovero D; Cafforio P; Duda L; Cormio G; Paradiso A; Palmirotta R; Silvestris F
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PGRN promotes migration and invasion of epithelial ovarian cancer cells through an epithelial mesenchymal transition program and the activation of cancer associated fibroblasts.
    Dong T; Yang D; Li R; Zhang L; Zhao H; Shen Y; Zhang X; Kong B; Wang L
    Exp Mol Pathol; 2016 Feb; 100(1):17-25. PubMed ID: 26607602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microRNA-27a: ZBTB10-specificity protein pathway is involved in follicle stimulating hormone-induced VEGF, Cox2 and survivin expression in ovarian epithelial cancer cells.
    Lai Y; Zhang X; Zhang Z; Shu Y; Luo X; Yang Y; Wang X; Yang G; Li L; Feng Y
    Int J Oncol; 2013 Feb; 42(2):776-84. PubMed ID: 23254909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicle-stimulating hormone promotes nerve growth factor and vascular endothelial growth factor expression in epithelial ovarian cells.
    Garrido MP; Bruneau N; Vega M; Selman A; Tapia JC; Romero C
    Histol Histopathol; 2020 Sep; 35(9):961-971. PubMed ID: 32369181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HYOU1 promotes cell growth and metastasis via activating PI3K/AKT signaling in epithelial ovarian cancer and predicts poor prognosis.
    Li X; Zhang NX; Ye HY; Song PP; Chang W; Chen L; Wang Z; Zhang L; Wang NN
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(10):4126-4135. PubMed ID: 31173282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
    BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.